Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Enterologics, Inc. | Financial_Report.xls |
| EX-32.1 - CERTIFICATION - Enterologics, Inc. | elgo_ex321.htm |
| EX-31.2 - CERTIFICATION - Enterologics, Inc. | elgo_ex312.htm |
| EX-31.1 - CERTIFICATION - Enterologics, Inc. | elgo_ex311.htm |
| EX-10.20 - EXTENSION OF LOI WITH UNIVERSAL STABILIZATION TECHNOLOGIES, INC. - Enterologics, Inc. | elgo_ex1020.htm |
| EX-10.21 - DEMAND PROMISSORY NOTE - Enterologics, Inc. | elgo_ex1021.htm |
| EX-10.22 - DEMAND PROMISSORY NOTE - Enterologics, Inc. | elgo_ex1022.htm |
| EX-10.23 - DEMAND PROMISSORY NOTE - Enterologics, Inc. | elgo_ex1023.htm |
| 10-Q - FORM 10-Q - Enterologics, Inc. | elgo_10q.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Lawrence Levitan, M.D., Treasurer and Director of Enterologics, Inc. (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: May 20, 2013
|
By:
|
/s/ Lawrence Levitan, M.D. | |
| Name: Lawrence Levitan, M.D. | |||
| Title: Treasurer (Principal Financial and Accounting Officer) and Director |
This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.